Dr. Archie Defillo has over 25 years of clinical experience with neurological diseases.  His research interests include cerebrovascular, stroke, neuro-trauma, brain oxygenation, metabolism and autonomic dysfunction.  He was also a co-investigator, together with the famous Australian neurosurgeon Professor Dorsch in the Bayer founded worldwide, multi-center, Nimodipine trial. Dr. Defillo was also the lead clinical researcher at the National Brain Aneurysm Center in St. Paul, Minnesota.  Dr. Defillo is a scientific member of Congress of Neurological Surgeons and board member of few editorial journals. Currently, he holds more than 50 publications including topics in resting heart rate, heart rate variability, and broken heart syndrome.  His time at Medibio has been dedicated to advancing the knowledge between heart rate variability and autonomic modulation as it relates to mental health.

Kai is an experienced investor, strategic advisor and executive who currently oversees the investment portfolio for a family office based in Perth. He has deep experience in strategy and governance in the med-tech and wellbeing industries and works closely with founders to establish and implement commercialisation strategies. Previously, he scaled one of the largest corporate health and fitness platforms in Australia and holds a Bachelors of Laws and Commerce from the University of Western Australia. At Medibio, Kai works closely with the CEO to facilitate the company’s short and long term strategic plans and is responsible for all non-regulatory operations.

Massimiliano Grassi has 15 years of experience as a researcher and data scientist in the field of mental health. At Medibio his work has been focused on the development of machine learning algorithms for the identification of sleep staging and depressive burden. He is also a clinical psychologist at Villa San Benedetto Menni Hospital and an adjunct professor at Humanitas University.

Dr. Perna is the Chairman of the Dept. of Clinical Neurosciences at San Benedetto Menni Hospital of the Hermanas Hospitalarias (Como Lake) and the Academic Coordinator of the Mental Health Area of the International Medical School & Professor in Psychiatry, Humanitas University (Milan). He is also Voluntary Professor, Department of Psychiatry & Behavioral Sciences, Miami University, and Director of the International Master in Affective Neurosciences and Associate Professor at Maastricht University, Chair of the WPA section on Personalized Psychiatry & Co-editor in chief of Personalized Medicine in Psychiatry (Elsevier). Dr. Perna’s team consists of 2 attending psychiatrists, 4 psychologists and 2 data scientists. Professor Perna is one of the world experts on panic attack. He is a well-accomplished researcher and author of many scientific publications.